BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 29266779)

  • 21. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy.
    Qin WD; Liu GL; Wang J; Wang H; Zhang JN; Zhang F; Ma Y; Ji XY; Li C; Zhang MX
    Oncotarget; 2016 Jun; 7(24):35618-35631. PubMed ID: 27027354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
    Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
    Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat.
    Tate M; Deo M; Cao AH; Hood SG; Huynh K; Kiriazis H; Du XJ; Julius TL; Figtree GA; Dusting GJ; Kaye DM; Ritchie RH
    Diab Vasc Dis Res; 2017 Sep; 14(5):423-433. PubMed ID: 28565941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats.
    Diao J; Wei J; Yan R; Fan G; Lin L; Chen M
    J Physiol Biochem; 2019 Feb; 75(1):39-51. PubMed ID: 30225723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling.
    Gao L; Liu Y; Guo S; Xiao L; Wu L; Wang Z; Liang C; Yao R; Zhang Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3322-3338. PubMed ID: 30031228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exogenous Hydrogen Sulfide Attenuates Cardiac Fibrosis Through Reactive Oxygen Species Signal Pathways in Experimental Diabetes Mellitus Models.
    Zheng D; Dong S; Li T; Yang F; Yu X; Wu J; Zhong X; Zhao Y; Wang L; Xu C; Lu F; Zhang W
    Cell Physiol Biochem; 2015; 36(3):917-29. PubMed ID: 26088607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption.
    Motyl KJ; Raetz M; Tekalur SA; Schwartz RC; McCabe LR
    Am J Physiol Regul Integr Comp Physiol; 2011 May; 300(5):R1250-60. PubMed ID: 21346244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telmisartan and thiorphan combination treatment attenuates fibrosis and apoptosis in preventing diabetic cardiomyopathy.
    Malek V; Gaikwad AB
    Cardiovasc Res; 2019 Feb; 115(2):373-384. PubMed ID: 30184174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes.
    Tikellis C; Pickering R; Tsorotes D; Du XJ; Kiriazis H; Nguyen-Huu TP; Head GA; Cooper ME; Thomas MC
    Clin Sci (Lond); 2012 Oct; 123(8):519-29. PubMed ID: 22616805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice.
    Shiota A; Yamamoto K; Ohishi M; Tatara Y; Ohnishi M; Maekawa Y; Iwamoto Y; Takeda M; Rakugi H
    Hypertens Res; 2010 Apr; 33(4):298-307. PubMed ID: 20186149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth differentiation factor 11 regulates high glucose-induced cardiomyocyte pyroptosis and diabetic cardiomyopathy by inhibiting inflammasome activation.
    Zhang J; Wang G; Shi Y; Liu X; Liu S; Chen W; Ning Y; Cao Y; Zhao Y; Li M
    Cardiovasc Diabetol; 2024 May; 23(1):160. PubMed ID: 38715043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes of CCAAT enhancer-binding proteins (CEBPs) in the lung of streptozotocin-induced diabetic rats.
    Fong Y; Shen KH; Chen LJ; Cheng JT
    Horm Metab Res; 2011 Apr; 43(4):261-7. PubMed ID: 21249617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mdm2 promotes myogenesis through the ubiquitination and degradation of CCAAT/enhancer-binding protein β.
    Fu D; Lala-Tabbert N; Lee H; Wiper-Bergeron N
    J Biol Chem; 2015 Apr; 290(16):10200-7. PubMed ID: 25720496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment with crocin improves cardiac dysfunction by normalizing autophagy and inhibiting apoptosis in STZ-induced diabetic cardiomyopathy.
    Feidantsis K; Mellidis K; Galatou E; Sinakos Z; Lazou A
    Nutr Metab Cardiovasc Dis; 2018 Sep; 28(9):952-961. PubMed ID: 30017436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
    Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
    J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of high-mobility group box 1 improves myocardial fibrosis and dysfunction in diabetic cardiomyopathy.
    Wang WK; Wang B; Lu QH; Zhang W; Qin WD; Liu XJ; Liu XQ; An FS; Zhang Y; Zhang MX
    Int J Cardiol; 2014 Mar; 172(1):202-12. PubMed ID: 24485636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCAAT/enhancer-binding protein β regulates interleukin-6-induced transmembrane and ubiquitin-like domain containing 1 gene expression in hepatocytes.
    Liu M; Yuan T; Liu H; Chen P
    Mol Med Rep; 2014 Oct; 10(4):2177-83. PubMed ID: 25109894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The protective effects of endogenous hydrogen sulfide modulator, S-propargyl-cysteine, on high glucose-induced apoptosis in cardiomyocytes: A novel mechanism mediated by the activation of Nrf2.
    Yang H; Mao Y; Tan B; Luo S; Zhu Y
    Eur J Pharmacol; 2015 Aug; 761():135-43. PubMed ID: 25979858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valsartan protects against ER stress-induced myocardial apoptosis via CHOP/Puma signaling pathway in streptozotocin-induced diabetic rats.
    Wu T; Dong Z; Geng J; Sun Y; Liu G; Kang W; Zhang Y; Ge Z
    Eur J Pharm Sci; 2011 Apr; 42(5):496-502. PubMed ID: 21345370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
    Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
    J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.